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Whey proteinThe aim of the study was to investigate the effect of leucine supplementation combined with exercise and
whey protein in cardiac mTOR anabolic pathway. Ninety-six weanling male Wistar rats were divided into
eight groups and fed diets containing either casein or WP plus increasing levels (0, 3, 4.5 and 6% of diet) of
L-leucine for 30 days. A parallel set of eight groups was exercised for comparison. Serum aspartate amino
transferase, alanine aminotransferase, creatine kinase, lactate dehydrogenase and branched chain amino
acids were determined by standard methods, and mammalian target of rapamycin (mTOR) and p70S6K by
the Western blot analysis. Chronic L-leucine supplementation was capable of increasing both mTOR and
p70S6K phosphorylation in the heart in a dose-dependent fashion, independent of the type of dietary protein
in both groups, sedentary and exercised, but the exercise potentialized the activation of the anabolic path-
way. The content of protein in heart increase with L-leucine supplementation and the heart mass relativized
by body mass did not change. In conclusion, the combination of L-leucine and milk proteins (casein or whey
protein) has the potential to increase the mTOR pathway in the cardiac muscle without increasing the heart
mass. The novelty of this study is to show the effectiveness of a blend of leucine and whey protein as a viable
alternative to maximize the activation of the anabolic pathway of cardiac muscle and that the exercise can
improve this process.
© 2013 Elsevier Ltd. All rights reserved.1. Introduction
Cardiac hypertrophy involves increased heart size due to in-
creased cardiomyocyte size. This is initially an adaptive response to
an increased workload or to defects in the efﬁciency of the contractile
machinery, but in the long term it contributes to the development of
heart failure and sudden death (Frey & Olson, 2003). Increased pro-
tein synthesis is a key feature of cardiac hypertrophy and probably
underlies the increased cell and organ size observed under this condi-
tion (Hannan, Jenkins, Jenkins, & Brandenburger, 2003). Several other
features are also seen, including changes in gene expression and reor-
ganization of the contractile machinery, and it should be borne in
mind that the protein accumulation characteristic of hypertrophy
may reﬂect effects on protein breakdown as well as protein synthesis.aspartate amino transferase;
atine kinase; ISO, L-isoleucine;
mmalian target of rapamycin
tion, Faculty of FoodEngineering,
ampinas, SP, Brazil. Tel.: +55 19
ollo).
rights reserved.Heart hypertrophy is linked to activation of mTOR pathway, and this
fact can improve the muscle function, which is a common process in
athletes. On the other hand, the pathological hypertrophy is associat-
ed with an activation increase of calmodulin, which is associated with
loss-of-function of the heart muscle (McMullen & Jennings, 2007).
L-Leucine is a branched-chain amino acid that has been the subject
of much investigation and is considered capable of stimulating cell
protein synthesis (Anthony, Anthony, Kimball, & Jefferson, 2001;
Drummond & Rasmussen, 2008). Nevertheless, its effectiveness has
been reported to fail under such situations as sepsis, alcohol intoxica-
tion and high (excess) glucocorticoid levels in old rats (Anthony &
Anthony, 2008). The attenuation of in vivo skeletal muscle proteolysis
by L-leucine has also been described, but is less documented than for
protein synthesis. Anthony, Anthony, and Layman (1999) reported
that L-leucine increased skeletal muscle protein synthesis when
given alone to rats following exercise. The main mechanism by
which L-leucine exerts its protein synthesis stimulating function is
by activating mTOR, a key protein in the process of cell proliferation
(Proud, 2007). Once activated, mTOR phosphorylates and activates
S6K1 and 4E-BP1 is inactivated. Activation of p70s6k is linked to pref-
erential translation of messenger RNAs containing a polypyrimidine
stretch in their 5′ untranslated region. While, the phosphorylation
of 4E-BP1 decreases its binding to eIF4E and release of 4E-BP1 from
Fig. 1. Distribution of groups (n = 6). The AIN93-G WP diet was made by substituting
the whey protein (WP) for the casein (CAS) of the AIN93 (standard) diet. The controls
contained no added L-leucine.
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Active eIF4E is associatedwith higher translation of RNAs, thus increasing
the cell capacity to synthesize proteins (Proud, 2007). Besides the anabol-
ic effect gained through the activation of mTOR, L-leucine also stimulates
insulin secretion (Bolster, Kimball, & Jefferson, 2003), thereby giving a fur-
ther boost to anabolism. There is also evidence that supplementationwith
L-leucine for prolonged periods of time may have an anti-catabolic effect
in skeletal muscle (Sugawara, Ito, Nishizawa, & Nagasawa, 2007).
The principal effects of the activation of protein synthesis by
L-leucine have been described for skeletal muscle, and its characteris-
tics are maintained even in animals undergoing training (Anthony et
al., 2001). Despite this, little attention has been given to the effects of
this supplementation on the cardiac muscle. It is well known that
high quality proteins can stimulate protein synthesis at higher rates
than lower quality proteins (Yoshizawa, Kido, & Nagasawa, 1999).
The whey proteins possess high nutritive quality and a high speed
of digestion and absorption, thus providing a fast and profuse supply
of amino acids and small peptides (Morato et al., 2013), with a signif-
icant impact on the turnover of body proteins. For this reason, whey
proteins have been recognized as promoting a positive metabolic bal-
ance, being classiﬁed by some researchers as rapid metabolism
proteins (Fruhbeck, 1998), making them attractive for situations
of metabolic stress, including that caused by physical exercise (de
Moura, Lollo, Morato, Carneiro, & Amaya-Farfan, 2013), muscle mass
loss (Lollo et al., 2012) and immune deﬁciencies, among others
(Marshall, 2004). It may be relevant to note that the concentrations
of BCAA in whey proteins, including L-leucine, are high. Altogether,
BCAAs account for 21.2% of the amino acids that make up the whey
proteins, or exactly 50% of the total of indispensable amino acids
therein, a feature that is shared with few other proteins besides the
skeletal muscle proteins (Etzel, 2004; Ha & Zemel, 2003). Hulmi,
Lockwood, and Stout (2010) also reported that chronic (21 weeks)
supplementation with whey proteins favored resistance training-
induced muscle hypertrophy in young healthy individuals as compared
to a non-energetic placebo. These data suggest that chronic ‘high-quality
protein’ supplementation is able to improve exercise-induced muscle
mass gain and performance.
Elucidating the signaling connections underlying cardiac hyper-
trophy is important both for our fundamental understanding of the
process and for developing potential therapeutic strategies for this
condition, which is a major risk factor for cardiac failure. This is a vig-
orous research area and several signaling pathways have been impli-
cated in hypertrophic responses in cardiomyocytes (Frey & Olson,
2003; Molkentin & Dorn, 2001). The effect of the L-leucine plus
whey protein combination in skeletal muscle is clear, hypertrophy,
but not in the cardiac muscle. The aim of the study was to investigate
the effect of leucine supplementation combined with exercise and
whey protein on a cardiac protein synthesis activation (mTOR anabol-
ic pathway).2. Methods
2.1. Design
Male Wistar (21-day old, speciﬁc-pathogen free; n = 96) rats,
bred in the Multidisciplinary Center for Biological Research, Universi-
ty of Campinas, SP, Brazil, were housed (~22 °C, 55% RH, inverted
12-hour light cycle) in 96 individual growth cages (one per animal),
with free access to commercial chow (Labina, Purina, Brazil) and
water at all times, until they weighed 120.2 ± 4.7 g. The animals
were randomly assigned to any of sixteen groups according to the
protein source in the diet, L-leucine supplementation and whether
they were exercised or sedentary (Fig. 1). The research methodology
was approved by the Ethics Committee on Animal Experimentation
(CEEA-UNICAMP, protocol 1835-1).2.2. Training protocol
The rats were selected beforehand on the treadmill, considering as
not ﬁt those that remained without departing from the baseline for
30 s. The animals began training on the day they started to consume
the experimental diets, and continued for 4 weeks following the pro-
gressive protocol of Hohl et al. (2009), each week had ﬁve training
sessions, and one session per day between 01:00 and 03:00 pm, the
training sessions was, week 1): 20 min at 15 m/min; week 2): 30 min
at 20 m/min; week 3): 45 min at 22.5 m/min; week 4): 60 min, at
25 m/min.
2.3. Experimental diets
The experimental diets were isonitrogenous (approximately 17% pro-
tein, dry basis), isolipidic and isocaloric (approximately 360 kcal/100 g),
formulated following the recommendations of the American Institute of
Nutrition, AIN93 (for growing rats) diet (Reeves, Nielsen, & Fahey,
1993). The two diets differed with respect to the nature of the protein
source, casein or whey protein (Table 1), the L-leucine added was at
least 99.7% pure (Ajinomoto, São Paulo). All the animals received the
diets ad libitum.
2.4. Protein extraction and immunoblotting
The sampleswere prepared byhomogenizing ~100 mgof frozen tis-
sue in Triton buffer (100 mM Tris, pH 7.4, 1% Triton X-100) containing
100 mM sodium pyrophosphate, 100 mM NaF, 10 mM EDTA, 10 mM
Na3Vo4, 2 mM PMSF and 0.1 mg/ml aprotinin (Lollo et al., 2012). The
total protein content of the heart muscle was determined by the Lowry
method (Lowry, Rosebrough, Farr, & Randall, 1951). For immuno blot-
ting, tissue homogenates were subjected to SDS-PAGE and transferred
onto a nitrocellulose membrane, using a wide BiocomWestern blot sys-
tem (Bridge of Weir, UK). The blots were probed with the appropriate
antibodies to determine the total mTOR (dilution 1:1000, ref#2972)
and phosphor-mTOR (Ser 2448, dilution 1:1000, ref#2971S) using Cell
Signaling Technology (Danvers, MA) and total p70S6K (dilution
1:1000, ref#sc-9379) and phosphor-p70S6K (Thr389, dilution 1:1000,
ref#sc-11759) using Santa Cruz (Santa Cruz, CA). Beta-actin was the
loading control (dilution 1:2000, ref#ADI-905-733-100), obtained
from Enzo Life Sciences (Farmingdale, NY), and used to assess the
level of the proteins in the heart tissue. The appropriate secondary anti-
body conjugated to peroxidase and the BMchemiluminescence blotting
system was used for detection. The bands were visualized by chemilu-
minescence (GE — I mageQuant LAS4000, Piscataway, NJ, USA) and
the band intensities were quantiﬁed by processing with the program
ImageJ (v. 1.47J for Windows).
Table 1
Composition of the diets (g/kg diet).
Ingredient AIN93-G (casein) AIN93-G (whey protein)
Control 0%L +3%L +4.5%L +6%L Control 0%L +3%L +4.5%L +6%L
Leucine added − 30 45 60 − 30 45 60
Corn starch 403.4 373.4 358.4 343.4 407.3 377.3 362.3 347.3
Casein (87.6% protein) 194.1 194.1 194.1 194.1 − − − −
WP (89.4% protein) − − − − 190.2 190.2 190.2 190.2
Dextrinized corn starch 132 132 132 132 132 132 132 132
Sucrose 100 100 100 100 100 100 100 100
Soybean oil 70 70 70 70 70 70 70 70
Fiber 50 50 50 50 50 50 50 50
Mineral mix 35 35 35 35 35 35 35 35
Vitamin mix 10 10 10 10 10 10 10 10
L-cystine 3 3 3 3 3 3 3 3
Choline bitartrate 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5
Tert-butylhydroquinone 0.014 0.014 0.014 0.014 0.014 0.014 0.014 0.014
The AIN93-G WP diet was made by substituting the whey protein for the casein of the AIN93 (standard) diet plus leucine (L) added.
545P.C.B. Lollo et al. / Food Research International 53 (2013) 543–5502.5. Biochemical parameters
Kits for blood sampling. Six hours after the training session, blood
sampleswere collected in Vacutainers, kept at 4 °C, and then centrifuged
at 3000 ×g (4 °C, 12 min) to obtain the serum. The following determina-
tions were carried out to assess the sera: uric acid, aspartate amino
transferase (AST), alanine aminotransferase ALT, creatine kinase (CK)
and lactate dehydrogenase (LDH). Standard enzymatic spectrophoto-
metric determinations of glucose and cholesterol were also carried out
employing Laborlab kits (São Paulo, Brazil).
2.6. Determination of plasma free amino acids
Serum free amino acids were extracted with methanol and
derivatized with phenylisothiocyanate (White, Hart, & Fry, 1986) and
the PTH-derivatives chromatographed using a Luna C-18, 100 Ǻ; 5 μ,
250 × 4.6 mm (00G-4252-EQ) column, at 50 °C, and quantiﬁed by
comparison with a standard mixture using DL-2-aminobutyric acid as
the internal standard (Sigma-Aldrich Corp, St Louis, MO, USA). The
free amino acids were extracted in 80% ethanol and 0.1 M HCl, with
500 μL of 2-aminobutyric acid added as the internal standard. The
mixture was sonicated for 10 min and further homogenized for 1 h,
followed by centrifugation at 8500 ×g for 15 min. The supernatant
was ﬁltered through a 0.22 mm membrane and a 40 μL aliquot
derivatized as described above for the subsequent injection of 20 μL
into the liquid chromatograph.
2.7. Statistical analysis
The results were subjected to a statistical analysis using the SPSS
software (Statistical Package for the Social Sciences), version 17.0.
The data were tested for normality (Kolmogorov–Smirnov test) and
homogeneity using the tools available therein. For parametric data,
the two way multivariate analysis of variance (ANOVA) was used
and the means compared (Duncan test), adopting the value of
P ≤ 0.05 as a criterion for statistical signiﬁcance.
3. Results and discussion
Cardiac hypertrophy is an increase in heart mass and is a poor
prognostic sign, being a characteristic of most forms of heart failure.
On the other hand, in athletes, cardiac hypertrophy is known as a pos-
itive physiological hypertrophy and is associated with heart health
improvements. Signaling pathways play unique roles in the regulation
of pathological and physiological cardiac hypertrophy, mTOR activation
is associatedwith physiological hypertrophywhile calmodulin pathway
is linked to pathological hypertrophy (McMullen & Jennings, 2007).
In general, supplementing both casein and the whey protein withL-leucine promoted the expression of mTOR total and phosphorylated
and p70S6K total and phosphorylated in the heart muscle, at the level
of 4.5% and 6% (Figs. 2 and 3). However, the degree of response varied
according to whether the protein was casein or whey protein, and to
whether the animal belonged to a sedentary or trained group. The
supplementation with L-leucine by itself can increase the activation of
the mTOR pathway (CAS plus leucine supplementation), this result is
coherent with that of other authors (Sanchez Canedo et al., 2010;
Suryawan et al., 2012). This result was similar with whey protein like
source of protein of the diet.
For instance, supplementation of the casein-trained group (Fig. 2B)
with 4.5% L-leucine resulted in an increment in mTOR, however, at the
6% level the increment decreased, although it was still above the
basal level. The mTOR activation observed in the sedentary groups
supplementedwith casein followed a similar pattern (although slightly
higher) as compared to the trained groups (Fig. 2E–H), suggesting that
the supplementation with L-leucine is more effective in the mTOR
phosphorylation of sedentary rats. The mTOR activation is associat-
ed with physiological hypertrophy, which is a beneﬁcial event for
the heart. The training alone exerted the activation of the mTOR
pathway, so trained animals had a higher level of mTOR activation
as compared to sedentary rats. Furthermore, the supplementation
with L-leucine slightly increased the mTOR phosphorylation. Per-
haps the activation of signaling pathways of protein synthesis in
healthy animals, for a long period, would cause a negative feedback
and an increase in the activation of catabolic pathways, such as the
ubiquitin proteosome pathway. This would be a possible explana-
tion for the fact that the heart mass remains unchanged even with
greater activation of anabolic pathways.
With regard to the stimulatory effect of supplementation on the ex-
pression of the phosphorylated form of mTOR (S2448), it was observed
that regardless of the type of protein, the effect only showed a tendency
to peakwith the addition of 4.5% in the sedentary groups, whereas in the
trained groups, the effect increased with every successive addition
(Fig. 2), different of diaphragm response magnitude (Lollo et al., 2012).
In the heart, mTOR is an important regulator of cardiac hypertrophy
and rapamycin, an inhibitor ofmTOR, can attenuate load-induced cardiac
hypertrophy in mice (Shioi et al., 2003). L-leucine is a very effective
amino acid with an insulinotropic effect (Anthony et al., 2002), and the
insulin can increase the activation ofmTOR on serine 2448, leading to in-
creasedprotein synthesis via phosphorylation of the downstream targets
p70S6K and 4EBP1 (Proud, 2007). The over-expression of Akt/PKB by in-
sulin, an upstream regulator of mTOR, results in cardiac hypertrophy
(Shioi et al., 2003), and the regulation of cell size by Akt is thought to
be mediated by its phosphorylation and by the subsequent downstream
phosphorylation of mTOR on serine 2448.
The expression of phosphorylated p70 S6 kinase seemed to be higher
in animals supplemented with WP as compared to those supplemented
Fig. 2. mTOR and phosphorylated (S2448) mTOR response for casein (CAS [A, B, E and F]) and whey protein (WP [C, D, G and H]) to the three degrees of supplementation with
L-leucine in both the sedentary □ (A, C, E and G) and trained ■ (B, D, F and H) groups (n = 6). No different capital letters above the bars denote no signiﬁcant differences between
diets– exercise, different small letters indicate signiﬁcant differences between groups, two-way ANOVA was used and means were compared (Duncan test), adopting the value of
P b 0.05 as a criterion for statistical signiﬁcance.
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and sedentary groups (Fig. 3F and 3G), while the sedentary group
supplemented with casein reached the peak of activation with 4.5% of
L-leucine. The peak of activation occurred when 6% was supplemented
for trained rats (for both WP and casein groups). We observed that the
increased activation of p70 occurred in trained animals, suggesting that
supplementation with L-leucine is more effective if given to animalssubjected to exercise, and these data are consistent with the results of
heart mass/body mass (Fig. 4A) and heart protein/body mass (Fig. 4D).
All this information demonstrates that there is a signiﬁcant anabolic
effect of training associated with L-leucine supplementation on markers
of cardiac hypertrophy. In animal models, L-leucine was shown to
have a stimulatory effect on protein synthesis, independent of insulin
(Anthony et al., 1999; Anthony et al., 2002). Anthony et al. (2002)
Fig. 3. p70S6K and p70S6K phosphorylated (Y389) response for casein (CAS [A, B, E and F]) and WP (whey protein [C, D, G and H]) to the three degrees of supplementation with
L-leucine in both the sedentary□ (A, C, E and G) and trained ■ (B, D, F and H) groups (n = 6). CAS: casein like source of protein of the diet; WP: whey protein like source of protein
of the diet; +3: diet with 3% of L-leucine; 4.5%: diet with 3% of L-leucine; 6%: diet with 3% of L-leucine. No different capital letters above the bars denote no signiﬁcant differences
between diets–exercise, different small letters indicate signiﬁcant differences between groups, two-way ANOVA was used and means were compared (Duncan test), adopting the
value of P b 0.05 as a criterion for statistical signiﬁcance.
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tein synthesis in rats, even if the concentration of insulin in the bloodwas
maintained low by the concomitant infusion of somatostatin. Thus the
data presented suggest that although L-leucine itself can stimulate therelease of insulin, the greater part of the anabolic effect is probably not
due to the action of insulin (Anthony et al., 2002).
Finally, it is noteworthy to observe the high concentrations of
BCAA, including L-leucine, present in the whey proteins. Altogether,
Fig. 4. Response of heart mass and protein contend, total and relativized for body mass of sedentary□ and trained ■ (n = 6). Casein (CAS): casein like source of protein of the diet;
whey protein (WP): whey protein like source of protein of the diet; +3: diet with 3% of L-leucine; 4.5%: diet with 3% of L-leucine; 6%: diet with 3% of L-leucine. No different capital
letters above the bars denote no signiﬁcant differences between diets–exercise, different letters indicate signiﬁcant differences between groups, two-way ANOVA was used and
means were compared (Duncan test), adopting the value of P b 0.05 as a criterion for statistical signiﬁcance.
548 P.C.B. Lollo et al. / Food Research International 53 (2013) 543–550BCAAs account for 21.2% of the amino acids that make up the whey
proteins, or exactly 50% of the total of indispensable amino acids
contained therein. This signiﬁes that BCAAs are predominantly contained
in these proteins in contrast to most other proteins (Etzel, 2004). This
particular feature of the whey proteins means that they approach the
amino acid proﬁle of the skeletal muscle proteins (Ha & Zemel, 2003).
Another characteristic of the whey proteins is their capacity
to stimulate the secretion of the anabolic hormone insulin into the
bloodstream, thereby increasing the transport of amino acids into
the cell and setting up the necessary conditions for protein synthesis
(Calbet & MacLean, 2002). L-leucine has been proved to reduce
lyzosomal and ATP-dependent protein degradation (Busquets et al.,
2000).
At the cellular level, cardiomyocyte hypertrophy is characterized
by an increase in cell size, enhanced protein synthesis and heightened
organization of the sarcomere. Hypertrophic growth accompanies
many forms of heart disease, including ischemic disease, hyperten-
sion, heart failure and valvular disease (Frey, Katus, Olson, & Hill,
2004), and ventricular hypertrophy is associated with a signiﬁcantly
increased risk of heart failure and malignant arrhythmia (Koren,
Devereux, Casale, Savage, & Laragh, 1991). The body-mass adjusted
lean heart mass increased as the body mass departed from a mini-
mum of about 300 g, while in turn, the body mass varied between
the set extremes. This function also showed that the mass of the
heart was more inﬂuenced by a high body mass than by a high con-
tent of L-leucine in the diet. The minimum relative heart mass was
found at around a body mass of 290 g and a total L-leucine intake ofabout 20 g/kg of diet. Overall, Fig. 4 shows that trained rats presented
higher heart/body mass, signaling physiological hypertrophy, the con-
tent of protein in the heart (estimated by % of heart protein x mass tis-
sue) suggests that the L-leucine supplementation improves this content
in rats supplemented with 4.5% and 6% in trained animals that received
casein in diet. It is not yet known what the signiﬁcance of this outcome
could be, but one possibility is that since increases in the total contents
of L-leucine promote increases in bodymass, beyond a certain point the
corresponding increases in heart mass become disproportionately
greater, with no associated bearings on the general health of the
animals.
The consequences of supplementation on the activities of the AST
and ALT enzymes, plus the serum levels of glucose, uric acid, creati-
nine and cholesterol were determined, in order to further assess the
impact of the supplemental L-leucine in liver healthy parameters
(AST and ALT), no alterations were observed. In addition, there
were no alterations in the heart cell damage indicators, CK and LDH
(Dawie, Chawla, Worku, & Azazh, 2011) (Table 2) suggesting no dam-
age to the heart cells due to whey protein or L-leucine supplementa-
tion, suggestion of a safety strategy.
No signiﬁcant difference was observed in serum insulin among
groups (Table 2), but it must be noted that 12 hour fasted animals
were used, that is, rats had no intake of L-leucine. It is known that
the insulinotropic effect of insulin occurs within 2 or 3 h after inges-
tion of foods (Anthony et al., 2002), we emphasize that the skeletal
muscle seemed to be more sensitive to the stimulatory effects of insu-
lin than the cardiac muscle (Forsyth & Vary, 2008).
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Supplementation with L-leucine and whey protein effectively acti-
vated the cardiac mTOR pathway, the heart mass/body mass increase
in the trained groups supplemented with 4.5% and 6% of L-leucine,
feed with casein. The novelty of this study was to show the effective-
ness of the blend of leucine andmilk proteins as a viable alternative to
maximize the activation of the anabolic pathway of the cardiac muscle
of trained rats. Additionally, this combination of nutrients can provide
essential amino acids for synthesis of heart protein, and this can be use-
ful especially in circumstances ofweakness of the heartmuscle. AST and
ALT, which are enzyme markers of acute hepatocellular injury, and CK
and LDH,which are indicators of cardiac cell integrity, were not affected
by the supplementation. Higher doses of L-leucine supplementation
resulted in less body weight gains.
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